163 related articles for article (PubMed ID: 31170812)
1. Recombinant Human Platelet-Derived Growth Factor BB in Combination With a Beta-Tricalcium Phosphate (rhPDGF-BB/β-TCP)-Collagen Matrix as an Alternative to Autograft.
Daniels TR; Anderson J; Swords MP; Maislin G; Donahue R; Pinsker E; Quiton JD
Foot Ankle Int; 2019 Sep; 40(9):1068-1078. PubMed ID: 31170812
[TBL] [Abstract][Full Text] [Related]
2. Prospective Randomized Controlled Trial of Hindfoot and Ankle Fusions Treated With rhPDGF-BB in Combination With a β-TCP-Collagen Matrix.
Daniels TR; Younger AS; Penner MJ; Wing KJ; Le IL; Russell IS; Lalonde KA; Evangelista PT; Quiton JD; Glazebrook M; DiGiovanni CW
Foot Ankle Int; 2015 Jul; 36(7):739-48. PubMed ID: 25848134
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human platelet-derived growth factor-BB and beta-tricalcium phosphate (rhPDGF-BB/β-TCP): an alternative to autogenous bone graft.
DiGiovanni CW; Lin SS; Baumhauer JF; Daniels T; Younger A; Glazebrook M; Anderson J; Anderson R; Evangelista P; Lynch SE;
J Bone Joint Surg Am; 2013 Jul; 95(13):1184-92. PubMed ID: 23824386
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of lumbar spinal fusion utilizing recombinant human platelet derived growth factor-B chain homodimer (rhPDGF-BB) combined with a bovine collagen/β-tricalcium phosphate (β-TCP) matrix in an ovine model.
Gadomski BC; Labus KM; Puttlitz CM; McGilvray KC; Regan DP; Nelson B; Seim HB; Easley JT
JOR Spine; 2021 Sep; 4(3):e1166. PubMed ID: 34611589
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Patient Age on Foot and Ankle Arthrodesis Supplemented with Autograft or an Autograft Alternative (rhPDGF-BB/β-TCP).
Berlet GC; Baumhauer JF; Glazebrook M; Haddad SL; Younger A; Quiton JD; Fitch DA; Daniels TR; DiGiovanni CW
JB JS Open Access; 2020; 5(4):. PubMed ID: 33376929
[TBL] [Abstract][Full Text] [Related]
6. The Importance of Sufficient Graft Material in Achieving Foot or Ankle Fusion.
DiGiovanni CW; Lin SS; Daniels TR; Glazebrook M; Evangelista P; Donahue R; Beasley W; Baumhauer JF
J Bone Joint Surg Am; 2016 Aug; 98(15):1260-7. PubMed ID: 27489316
[TBL] [Abstract][Full Text] [Related]
7. A retrospective review of recombinant human platelet-derived growth factor with beta-tricalcium phosphate bone graft substitute use in hindfoot and/or ankle arthrodesis.
Loveland JD
J Orthop; 2023 Oct; 44():93-98. PubMed ID: 37727282
[TBL] [Abstract][Full Text] [Related]
8. A Multicenter, Retrospective, Case Series of Patients With Charcot Neuroarthropathy Deformities Undergoing Arthrodesis Utilizing Recombinant Human Platelet-derived Growth Factor With Beta-Tricalcium Phosphate.
Loveland JD; McMillen RL; Cala MA
J Foot Ankle Surg; 2021; 60(1):74-79. PubMed ID: 33158722
[TBL] [Abstract][Full Text] [Related]
9. Prospective, randomized, multi-center feasibility trial of rhPDGF-BB versus autologous bone graft in a foot and ankle fusion model.
Digiovanni CW; Baumhauer J; Lin SS; Berberian WS; Flemister AS; Enna MJ; Evangelista P; Newman J
Foot Ankle Int; 2011 Apr; 32(4):344-54. PubMed ID: 21733435
[TBL] [Abstract][Full Text] [Related]
10. Prospective clinical pilot trial in a single cohort group of rhPDGF in foot arthrodeses.
Daniels T; DiGiovanni C; Lau JT; Wing K; Younger A
Foot Ankle Int; 2010 Jun; 31(6):473-9. PubMed ID: 20557811
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human platelet-derived growth factor-BB versus autologous bone graft in foot and ankle fusion: A systematic review and meta-analysis.
Sun H; Lu PP; Zhou PH; Sun SW; Zhang HT; Liu YJ; Yang X; Shen XF; Yang HL
Foot Ankle Surg; 2017 Mar; 23(1):32-39. PubMed ID: 28159040
[TBL] [Abstract][Full Text] [Related]
12. Platelet-derived growth factor stimulates bone fill and rate of attachment level gain: results of a large multicenter randomized controlled trial.
Nevins M; Giannobile WV; McGuire MK; Kao RT; Mellonig JT; Hinrichs JE; McAllister BS; Murphy KS; McClain PK; Nevins ML; Paquette DW; Han TJ; Reddy MS; Lavin PT; Genco RJ; Lynch SE
J Periodontol; 2005 Dec; 76(12):2205-15. PubMed ID: 16332231
[TBL] [Abstract][Full Text] [Related]
13. On a quest to dethrone the long-reigning king: commentary on an article by Christopher W. DiGiovanni, MD, et al.: "Recombinant Human platelet-derived growth factor-BB and beta-tricalcium phosphate (rhPDGF-BB/β-TCP): an alternative to autogenous bone graft".
Gugala Z
J Bone Joint Surg Am; 2013 Jul; 95(13):e95. PubMed ID: 23824400
[No Abstract] [Full Text] [Related]
14. The evolution of rhPDGF-BB in musculoskeletal repair and its role in foot and ankle fusion surgery.
DiGiovanni CW; Petricek JM
Foot Ankle Clin; 2010 Dec; 15(4):621-40. PubMed ID: 21056861
[TBL] [Abstract][Full Text] [Related]
15. Growth factor-mediated treatment of recession defects: a randomized controlled trial and histologic and microcomputed tomography examination.
McGuire MK; Scheyer ET; Schupbach P
J Periodontol; 2009 Apr; 80(4):550-64. PubMed ID: 19335074
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous injection of augment injectable bone graft (rhPDGF-BB and β-tricalcium phosphate [β-TCP]/bovine type I collagen matrix) increases vertebral bone mineral density in geriatric female baboons.
Perrien DS; Young CS; Alvarez-Urena PP; Dean DD; Lynch SE; Hollinger JO
Spine J; 2013 May; 13(5):580-6. PubMed ID: 23541446
[TBL] [Abstract][Full Text] [Related]
17. Clinical Outcomes of Nonunions of Hindfoot and Ankle Fusions.
Krause F; Younger AS; Baumhauer JF; Daniels TR; Glazebrook M; Evangelista PT; Pinzur MS; Thevendran G; Donahue RM; DiGiovanni CW
J Bone Joint Surg Am; 2016 Dec; 98(23):2006-2016. PubMed ID: 27926682
[TBL] [Abstract][Full Text] [Related]
18. Effect of implantation of Augment(®) Bone Graft on serum concentrations of platelet-derived growth factors: a pharmacokinetic study.
Solchaga LA; Daniels T; Roach S; Beasley W; Snel LB
Clin Drug Investig; 2013 Feb; 33(2):143-9. PubMed ID: 23334906
[TBL] [Abstract][Full Text] [Related]
19. Release, biological potency, and biochemical integrity of recombinant human platelet-derived growth factor-BB (rhPDGF-BB) combined with Augment(TM) Bone Graft or GEM 21S beta-tricalcium phosphate (beta-TCP).
Young CS; Ladd PA; Browning CF; Thompson A; Bonomo J; Shockley K; Hart CE
J Control Release; 2009 Dec; 140(3):250-5. PubMed ID: 19577598
[TBL] [Abstract][Full Text] [Related]
20. Multi-centre, randomized clinical trial on the efficacy and safety of recombinant human platelet-derived growth factor with β-tricalcium phosphate in human intra-osseous periodontal defects.
Jayakumar A; Rajababu P; Rohini S; Butchibabu K; Naveen A; Reddy PK; Vidyasagar S; Satyanarayana D; Pavan Kumar S
J Clin Periodontol; 2011 Feb; 38(2):163-72. PubMed ID: 21133980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
